Skip to main content
. 2015 May 14;2(5):542–554. doi: 10.18632/oncoscience.162

Figure 5. Effect of doxorubicin in combination with kinase inhibitors on DNA damage response in PBMCs.

Figure 5

PBMCs were incubated with kinase inhibitors in the presence or absence of doxorubicin (1.7 uM) for 6 hr. Cells were harvested and processed for immunoblot analysis. Data from two separate experiments is shown.